Platelet-derived growth factor-BB inhibits rat α1D-adrenergic receptor gene expression in vascular smooth muscle cells by inducing AP-2-like protein binding to α1D proximal promoter region

Molecular Pharmacology

Volumn 56, Issue 6, 1999, Pages 1152-1161

  Xin, Xiaohua ^a   Yang, Nengyu ^a   Faber, James E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; TRANSCRIPTION FACTOR AP 2;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MATURATION; DENERVATION; DNA FLANKING REGION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT; RECEPTOR GENE; TATA BOX; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0032732282     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.6.1152     Document Type: Article

References (43)

1. Azizkhan JC, Jensen DE, Pierce AJ and Wade M (1993) Transcription from TATA-less promoters: Dihydrofolate reductase as a model. Crit Rev Eukaryotic Gene Expression 3:229-254.
2. Chen A, Beno DWA and Davis BH (1996) Suppression of stellate cell type I collagen gene expression involves AP-2 transmodulation of nuclear factor-1-dependent gene transcription. J Biol Chem 271:25994-25998.
3. Chen L-Q, Xin X, Eckhart AE, Yang NY and Faber JE (1995) Regulation of vascular smooth muscle growth by α1-adrenoceptor subtypes in vitro and in situ. J Biol Chem 270:30980-30988.
4. Clarke DE, Ford A PDW, Williams TJ, Bonhaus D, Vimont R and Blue DR Jr (1995) Pharmacological evidence for the equivalency of the α1A-adrenoceptor of rat and the cloned bovine α1C-adrenoceptor: a revised α1-adrenoceptor classification scheme. Pharmacol Res Commun 6:9-14.
5. Eckhart AD, Zhu Z, Arendshorst WJ and Faber JE (1996) Oxygen modulates α1B-adrenergic receptor gene expression by arterial but not venous vascular smooth muscle. Am J Physiol 271:H1599-H1608.
6. Eckhart AD, Yang N, Xin X and Faber JE (1997) Characterization of the α1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 94:9487-9492.
7. Faber JE, Yang N and Erami C (1999) Angioplasty injury reduces α-adrenergic receptor expression in neointima, media and adventitia. FASEB J 13:A515.
8. Fingerle J, Sanders KH and Fotev Z (1991) Alpha 1-receptor antagonists urapidil and prazosin inhibit neointima formation in rat carotid artery induced by balloon catheter injury. Basic Res Cardiol 86 (Suppl 1):75-81.
9. Gao B and Kunos G (1994) Transcription of the rat alpha 1B adrenergic receptor gene in liver is controlled by three promoters. J Biol Chem 269:15762-15767.
10. Gille J, Swerlick RA and Caughman SW (1997) Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J 16: 750-759.
11. Guarino RD, Perez DM and Piascik MT (1996) Recent advances in the molecular pharmacology of the alpha 1-adrenergic receptors. Cell Signal 8:323-333.
12. Gurdal H, Cai G and Johnson MD (1995) Alpha 1-adrenoceptor responsiveness in the aging aorta. Eur J Pharmacol 274:117-123.
13. Head RJ (1991) Hypernoradrenergic innervation and vascular smooth muscle hyperplasic change. Blood Vessels 28:173-178.
14. Hyman SE, Comb M, Pearlberg J and Goodman HM (1989) An AP-2 element acts synergistically with the cyclic AMP- and phorbol ester-inducible enhancer of the human proenkephalin gene. Mol Cell Biol 9:321-324.
15. Ibara M, Terron JA, Lopez-Guerrero JJ and Villalobos-Molina R (1997) Evidence for an age-dependent functional expression of alpha 1D-adrenoceptors in the rat vasculature. Eur J Pharmacol 322:221-224.
16. Imagawa M, Chiu R and Karin M (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP. Cell 51:251-260.
17. Iwasaki Y, Oiso Y, Saito H and Majzoub JA (1997) Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology 138:5266-5274.
18. Kannan P, Buettner R, Chiao PJ, Yim SO, Sarkiss M and Tainsky MA (1994) N-ras oncogene causes AP-2 tranacriptional self-interference, which leads to transformation. Genes Dev 8:1258-1269.
19. Kingsley C and Winoto A (1992) Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol 12: 4251-4261.
20. Kukreja RS, Datta BN and Chakravarti RN (1981) Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis 40:291-298.
21. Lee RMKW, Triggle CR, Cheung DWT and Coughlin MD (1987) Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rat. Hypertension 10:328-338.
22. Leech CJ and Faber JE (1996) Different alpha-adrenoceptor subtypes mediate constriction of arterioles and venules. Am J Physiol 270:H710-H722.
23. Lomasney JW, Cotecchia S, Lorenz W, Leung WY, Schwinn DA, Yang-Feng TL, Braunstein M, Lefkwoitz RJ and Caron MG (1991) Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J Biol Chem 266:6365-6369.
24. Luscher B, Mitthell PJ, Williams T and Tjian R (1989) Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev 3:1507-1517.
25. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN and Schwartz SM (1990) PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 111:2149-2158.
26. Panek RL, Dahring TK, Olszewski BJ and Keiser JA (1997) PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery. Arterioscler Thromb Vasc Biol 17:1283-1288.
27. Perez DM, Piascik MT and Graham RM (1991) Solution-phase library screening for the identification of rare clones: Isolation of an alpha 1D-adrenergic receptor cDNA. Mol Pharmcol 40:876-883.
28. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL and Perez DM (1995) The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 275:1583-1589.
29. Ping P and Faber JE (1993) Characterization of alpha-adrenoceptor gene expression in arterial and venous smooth muscle. Am J Physiol 265:H1501-H1509.
30. Rafty LA and Khachigian LM (1998) Zinc finger transcription factors mediate high constitutive platelet-derived growth factor-B expression in smooth muscle cells derived from aortae of newborn rats. J Biol Chem 273:5758-5764.
31. Razik MA, Lee K, Price RR, Williams MR, Ongjoco RR, Dole MK, Rudner XL, Kwartra MM and Schwinn DA (1997) Transcriptional regulation of the human alphala-adrenergic receptor gene. Characterization of the 5′-regulatory and promoter region. J Biol Chem 272:28237-28246.
32. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
33. Schwartz SM, deBlois D and O'Brian ERM (1995) The intima soil for atherosclerosis and restenosis. Circ Res 77:445-465.
34. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L and Wilcox JN (1996) Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93:2178-2187.
35. Uchida K, Sasahara M, Morigami N, Hazama F and Kinoshita M (1996) Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis 124:9-23.
36. Vashisht R, Sian M, Franks PJ and O'Malley MK (1992) Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosin. Br J Surg 79:1285-1288.
37. Williams T and Tjian R (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 5:670-682.
38. Xin X, Yang N, Eckhart AD and Faber JE (1997) α1D-adrenergic receptors and mitogen-activated protein kinase increase protein synthesis by arterial smooth muscle. Mol Pharmcol 51:764-775.
39. Xin X, Yang N and Faber JE (1999) Platelet-derived growth factor inhibits α1D-adrenergic receptor expression in vascular smooth muscle cells in vitro and ex vivo. Mol Pharmacol 56:1143-1151.
40. Yang N, Eckhart AD, Xin X and Faber JE (1997) CRE-like response element regulates expression of rat alpha 2D-adrenergic receptor gene in vascular smooth muscle. Am J Physiol 273:H85-H95.
41. Yang N, Erami C and Faber JE (1999) Adventitial fibroblasts express functional α1-adrenergic receptors, and modulate to myofibroblasts in primary culture and after angioplasty in vivo. FASEB J 13:A514.
42. Yang X, Fyodorov D and Deneris ES (1995) Transcriptional analysis of acetylcholine receptor alpha 3 gene promoter motifs that bind Sp1 and AP2. J Biol Chem 270:8514-8520.
43. Ye J, Xu RH, Taylor-Papadimitriou J and Pitha PM (1996) Sp1 binding plays a critical role in Erb-B2- and v-ras-mediated downregulation of alpha2-integrin expression in human mammary epithelial cells. Mol Cell Biol 16:6178-6189.